Biogen (BIIB) Change in Inventory (2009 - 2026)

Biogen (BIIB) has reported Change in Inventory for 18 consecutive years, with -$116.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Inventory fell 87.42% year-over-year to -$116.2 million; the TTM figure through Mar 2026 stood at $10.5 million (down 92.17% YoY), while the FY2025 annual figure was $64.7 million, down 76.37% from the prior year.
• Change in Inventory came in at -$116.2 million for Q1 2026 at Biogen, down from $29.4 million in the prior quarter.
• The five-year high for Change in Inventory was $142.6 million in Q1 2022, with the low at -$116.2 million in Q1 2026.
• Average Change in Inventory over 5 years is $39.6 million, with a median of $66.4 million recorded in 2024.
• Across the five-year window, Change in Inventory jumped 630.39% in 2023 and slumped 179.79% in 2025, its largest moves.
• Year by year, Change in Inventory stood at -$18.1 million in 2022, then surged by 630.39% to $96.0 million in 2023, then tumbled by 30.83% to $66.4 million in 2024, then slumped by 55.72% to $29.4 million in 2025, then tumbled by 495.24% to -$116.2 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered -$116.2 million, $29.4 million, and $7.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.